BamSEC and AlphaSense Join Forces
Learn More

BioRestorative Therapies Inc

NASDAQ: BRTX    
Share price (11/22/24): $1.48    
Market cap (11/22/24): $10.2 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from SCHEDULE 13G/A Underwriting agreement
12/34/56
EX-1.1
from 8-K 4 pages At the Market Offering Agreement
12/34/56
EX-1
from SC 13D/A 2 pages Incentive Stock Option Award Agreement Under the BioRestorative Therapies, Inc. 2021 Stock Incentive Plan
12/34/56
EX-1
from SC 13D/A 2 pages Incentive Stock Option Award Agreement Under the BioRestorative Therapies, Inc. 2021 Stock Incentive Plan
12/34/56
EX-1.1
from 8-K 42 pages BioRestorative Therapies, Inc. Common Stock ($0.0001 Par Value Per Share) Capital on Demand™ Sales Agreement
12/34/56
EX-1
from SC 13D/A 2 pages Incentive Stock Option Award Agreement Under the BioRestorative Therapies, Inc. 2021 Stock Incentive Plan
12/34/56
EX-1
from SC 13D/A 2 pages Incentive Stock Option Award Agreement Under the BioRestorative Therapies, Inc. 2021 Stock Incentive Plan
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 8-K 3 pages 2,300,000 Sharesof Common Stock and 2,300,000 Warrants of BioRestorative Therapies, Inc. Amended and Restated Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 42 pages Shares of Common Stock and Warrants of BioRestorative Therapies, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 65 pages Underwriting Agreement Between BioRestorative Therapies, Inc. and Aegis Capital Corp. BioRestorative Therapies, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 65 pages Underwriting Agreement Between BioRestorative Therapies, Inc. and Aegis Capital Corp. BioRestorative Therapies, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 64 pages Underwriting Agreement Between BioRestorative Therapies, Inc. and Aegis Capital Corp. BioRestorative Therapies, Inc. Underwriting Agreement
12/34/56